CJC-1295 (no dac) 6mg + Ipamorelin 11mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.

Product Overview

CJC-1295 (no DAC) / Ipamorelin is a dual-component research peptide blend developed for laboratory investigation of growth-hormone–related signalling pathways, receptor activation dynamics and endocrine feedback mechanisms. This lyophilized preparation combines two analytically verified peptides in a 6 mg and 11 mg configuration, supporting reproducible and well-controlled in vitro research applications.

Peptide Overview

CJC-1295 (MOD GRF 1-29) is a synthetic analogue of growth hormone–releasing hormone and has been studied since the late 1990s for its interaction with GHRH receptor pathways involved in pulsatile signalling models. Ipamorelin, introduced in research literature in the early 2000s, is a selective ghrelin-receptor agonist analogue investigated for its receptor specificity and reduced off-target activity in comparative endocrine studies.

When evaluated together, this peptide combination allows researchers to explore coordinated signalling behaviour, receptor synergy and temporal response patterns within endocrine-regulated biochemical systems.

Historical Background and Scientific Context

Research into growth hormone–associated peptides has expanded significantly over recent decades as laboratories sought to better understand endocrine regulation, pulsatile signalling mechanisms and downstream biochemical effects. Dual-peptide research models such as CJC-1295 and Ipamorelin have been widely referenced in preclinical literature as tools for studying combined receptor stimulation and feedback modulation under controlled experimental conditions.

Mechanistic Focus in Research

• Growth hormone–related receptor signalling analysis
• Endocrine feedback and pulse-modulation modelling
• Receptor selectivity and pathway interaction research
• Comparative structure–function investigation
• Controlled in vitro endocrine signalling studies

Analytical Verification (COA)

Independent Liquilabs analysis confirms full validation for Batch GF112025089. Key analytical results include:

• CJC-1295 Assay Content: 6.16 mg
• CJC-1295 Identification – Retention Time: 0.986
• Ipamorelin Assay Content: 11.09 mg
• Ipamorelin Identification – Retention Time: 0.998
• Endotoxins: below 0.001 EU per mg
• Microbial Growth: not detected
• Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures, ensuring transparent documentation and complete batch traceability.

Research Applications

• Endocrine and growth hormone signalling research
• Receptor interaction and pulse-modulation studies
• Biochemical feedback-loop analysis
• Comparative dual-peptide pathway evaluation
• Controlled in vitro signalling investigations

Grail Formula Quality

Every Grail Formula research peptide blend undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for low endotoxin levels, analytical consistency and reproducibility to support reliable scientific research outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptide materials with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

Verified and analysed with Liquilabs s.r.o. Czechia
Dual-peptide blend of CJC-1295 and Ipamorelin
Validated assay content 6.16 mg and 11.09 mg
No detectable heavy metals or microbial contamination
Endotoxin level below 0.001 EU per mg
Batch GF112025089 – Published January 2026
EU shipments include bacteriostatic water
For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.